Poster Viewing Session IV - Investigations & Treatment
Young Investigators present their poster in a short movie and reply live to questions moderated by the session chairs.
Log in or create an account to watch this content
Subscribe now and get unlimited access to all webinars and recordings.
Now Playing: Poster Viewing Session IV - Investigations & Treatment
Poster Viewing Session IV - Investigations & Treatment
Moderators: Hans-Peter Hartung & Oscar Fernández
- An imaging signature in choroid plexuses in pre-symptomatic multiple sclerosis: Vito Ricigliano (Paris, France)
- Functional brain states predict cognitive decline 5 years after a CIS: Ismail Koubiyr (Bordeaux, France)
- Retinal thinning predicts relapse remission in relapsing multiple sclerosis: Gabriel Bsteh (Vienna, Austria)
- Resting-state and structural MRI metrics related to fatigue in MS, MOGAD and NMOSD: Valentina Camera (Oxford, United Kingdom)
- Natalizumab extended-interval dosing is associated with subtle inflammatory changes: Marco Pisa (Milan, Italy)
- Visual pathway damage evolution in multiple sclerosis related acute optic neuritis: Simone Guerrieri (Milan, Italy)
- USPIO-SWI showed vascular factors involved in "black holes" in multiple sclerosis: Li-Jie Zhang (Fujian, China)
- Clinical and genetic features of MS in the Republic of Bashkortostan: Timur Galiulin (Ufa, Russia)
- Humoral immune response to COVID-19 Vaccines in patients with MS on different DMTs: Alexandra Akrivaki (Athens, Greece)
- TDCS to prevent optic nerve damage and to promote remyelination in EAE mouse model: Silvia Marenna (Milan, Italy)
- Systemic corticosteroid therapy and visual outcome of ischemic optic neuropathy: Sofia Bezerra de Oliveira Costa (Porto, Portugal)
- Characterisation of the immune system after ocrelizumab treatment in MS: Lien Beckers (Diepenbeek, Belgium)